Genomic analysis in Chilean patients with suspected Rett syndrome: keep a broad differential diagnosis

被引:0
|
作者
Brito, Florencia [1 ]
Lagos, Catalina [1 ]
Cubillos, Jessica [2 ]
Orellana, Joan [1 ]
Gajardo, Mallen [3 ]
Boehme, Daniela [1 ,4 ]
Encina, Gonzalo [4 ]
Repetto, Gabriela M. [1 ]
机构
[1] Clin Alemana Univ Desarrollo, Inst Sci & Innovat Med, Fac Med, Ctr Genet & Genom,Rare Dis Program, Santiago, Chile
[2] Fdn Ellas & Ellos Sindrome Rett, Santiago, Chile
[3] Univ Chile, Escuela Ingn, Fac Ciencias Fis & Matemat, Santiago, Chile
[4] Biosoluc UDD, Santiago, Chile
关键词
Rett syndrome; MeCP2; CpG methyl-binding protein; neurodevelopmental disorders; gene panel; genomic testing; CONGENITAL VARIANT; FOXG1; MUTATIONS; DIVERSITY; EPILEPSY; GENES;
D O I
10.3389/fgene.2024.1278198
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction: Rett syndrome (RTT, MIM #312750) is a rare genetic disorder that leads to developmental regression and severe disability and is caused by pathogenic variants in the MECP2 gene. The diagnosis of RTT is based on clinical features and, depending on resources and access, on molecular confirmation. There is scarce information on molecular diagnosis from patients in Latin America, mostly due to limited availability and coverage of genomic testing. This pilot study aimed to implement genomic testing and characterize clinical and molecular findings in a group of Chilean patients with a clinical diagnosis of RTT.Methods: Twenty-eight patients with suspected RTT underwent characterization of phenotypic manifestations and molecular testing using Clinical Exome SolutionTM CES_V2 by SOPHiA Genetics. Data was analyzed using the commercial bioinformatics platform, SOPHiA DDMTM. A virtual panel of 34 genes, including MECP2 and other genes that are in the differential diagnosis of RTT, was used to prioritize initial analyses, followed by evaluation of the complete exome sequence data.Results: Twelve patients (42.8% of participants) had variants in MECP2, of which 11 (39.2%) were interpreted as pathogenic/likely pathogenic (P/LP), thus confirming the diagnosis of RTT in them. Eight additional patients (28.5%) harbored ten variants in nine other genes. Four of these variants were interpreted as P/LP (14.2%) (GRIN2B, MADD, TRPM3 and ZEB2) resulting in alternative neurodevelopmental diagnoses, and six were considered of uncertain significance. No evident candidate variant was found for eight patients.Discussion: This study allowed to reach a diagnosis in half of the participants. The diagnosis of RTT was confirmed in over a third of them, while others were found to have alternative neurodevelopmental disorders. Further evaluation is needed to identify the cause in those with negative or uncertain results. This information is useful for the patients, families, and clinicians to guide clinical management, even more so since the development of novel therapies for RTT. We also show the feasibility of implementing a step-wide approach to genomic testing in a setting with limited resources.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Hypercalcemia in MGUS: keep the differential diagnosis broad
    Mian, Hira
    Visram, Alissa
    BLOOD, 2025, 145 (09) : 904 - 905
  • [2] Rett Syndrome: MECP2 gene molecular analysis in Chilean patients
    Aron W, Carolina
    Rauch L, Geraldinne
    Benavides G, Felipe
    Repetto L, M. Gabriela
    REVISTA CHILENA DE PEDIATRIA-CHILE, 2019, 90 (02): : 152 - 156
  • [3] Rett's syndrome:: clinical description and differential diagnosis
    Borges-González, S
    Rodríguez-Perrett, N
    Ferrando-Pollak, M
    REVISTA DE NEUROLOGIA, 2002, 34 (07) : 698 - 699
  • [4] A febrile syndrome with a broad differential diagnosis
    Ortega Perez, Juan
    Vidal Borras, Meritxell
    Alvarez Ferrer, Carlos Rafael
    Homar Amengual, Catalina
    Rodriguez Ocejo, Maria del Carmen
    Codinach Martin, Maria
    Comas Diaz, Bernardino
    Puiguriguer Ferrando, Jordi
    CLINICAL TOXICOLOGY, 2023, 61 : 53 - 53
  • [5] THE CLINICAL RECOGNITION AND DIFFERENTIAL-DIAGNOSIS OF RETT SYNDROME
    TREVATHAN, E
    NAIDU, S
    JOURNAL OF CHILD NEUROLOGY, 1988, 3 : S6 - S16
  • [6] The importance of genomic profiling for differential diagnosis of pediatric lung disease patients with suspected ciliopathies
    Andelkovic, Marina
    Spasovski, Vesna
    Vreca, Misa
    Sovtic, Aleksandar
    Rodic, Milan
    Komazec, Jovana
    Pavlovic, Sonja
    Minic, Predrag
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2019, 147 (3-4) : 160 - 166
  • [7] Comprehensive mutation analysis of the MECP2 gene and the analysis of 54 Rett syndrome suspected patients
    Vos, YJ
    Mol, GJJ
    Begeer, JH
    Verlind, E
    van den Akker, PC
    Buys, CHCM
    Hordijk, R
    Hofstra, RMW
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 230 - 230
  • [8] AUTISM AND RETT SYNDROME - SOME NOTES ON DIFFERENTIAL-DIAGNOSIS
    GILLBERG, C
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1986, 24 : 127 - 131
  • [9] The differential diagnosis of Rett syndrome under the age of five.
    MacLeod, P
    MOLECULAR PSYCHIATRY, 1999, 4 : S56 - S56
  • [10] AUTISM AND RETT-SYNDROME - BEHAVIORAL INVESTIGATIONS AND DIFFERENTIAL-DIAGNOSIS
    OLSSON, B
    RETT, A
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 1987, 29 (04): : 429 - 441